Navigation Links
Beike Biotech Adds International Executives to Strengthen Current Technologies and Develop Future Pipeline
Date:9/8/2009

SHENZHEN, China, Sept. 8 /PRNewswire-Asia/ -- Shenzhen Beike Biotechnology Co. Ltd. ( http://www.beikebiotech.com ), a leader in stem cell research and regenerative medicine, announced the appointment of two senior stem cell scientists to key positions in the company. Li Tao, Ph.D., joins as Lab Director of the iPS (induced Pluripotent Stem Cell) Laboratory, and Susan Jiang, M.D., Ph.D., has been named Chief Science Officer. Dr. Sean Hu, Ph.D., CEO and Chairman, will remain focused on furthering the company's research achievements while strengthening its position in the international biotechnology field.

Dr. Hu commented, "Beike has been at the forefront of stem cell technology in China and we are currently expanding throughout Asia. We are addressing a number of important factors to strengthen our credentials internationally, and we see Dr. Li Tao and Dr. Susan Jiang contributing greatly to this effort. Dr. Jiang will spearhead our initiatives to enhance our current technologies and increase their acceptance by the Western scientific community while Dr. Tao will lead a group developing a pipeline of emerging technologies for the coming five to ten years."

Dr. Tao comes to Beike with over 20 years of research experience in genetics, epigenetics, cell and stem cell biology, molecular biology, cancer biology and protein chemistry. He was most recently a senior research scientist at Stanford University's School of Medicine. During his six years at Stanford, he authored or co-authored 22 papers in peer-reviewed journals including Science, Human Molecular Genetics, Cancer Research and Genomics. Before Stanford, he earned his Ph.D. at Tokyo University and spent nine years in Japan working on genetics and genetic engineering, publishing articles in 16 international, peer-reviewed, jour
'/>"/>

SOURCE Shenzhen Beike Biotechnology Co. Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Stem Cell Leader Beike Signs 8 New Cooperation Agreements, Establishes Safety Monitoring Boards
2. Beike Biotech Opens Comprehensive Stem Cell Storage and Processing Facility in China
3. Former Manchester City Lord Mayor Has Hope Restored at New Beike Stem Cell Facility
4. Stem Cell Leader Beike Biotech and Chinas Tsinghua University Receive US$4 Million for Stem Cell Reprogramming Laboratory
5. Transcept Pharmaceuticals to Present at the BioCentury Thomson Reuters Newsmakers in the Biotech Industry Conference on September 16, 2009
6. TechConnect World 2010 Solving Global Technology Challenges with Clean Technology, Nanotechnology and Biotechnology
7. Biotech Cools Off in August But Capital Markets Remain Positive
8. China Kangtai Cactus Biotech to Launch Patented Cactus-based Low Tar, Low or Zero Nicotine Cigarettes
9. Champions Biotechnology to Deploy its Technology to Guide Development of Oncology Therapeutic for Global Biotech Leader
10. Oncolytics Biotech(R) Inc. Announces Issuance of 32nd U.S. Patent
11. SABiosciences Ranked 17th on the Best Places to Work Industry Award for Biotech and Pharmaceutical Companies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...RNewswire/ -- Dr. Mate Hidvegi, inventor of Avemar... release issued on November 17 by Biropharma Kft, ...e and self-serving statements about its U.S. compe...ted from his office in Budapest, Hungary: ,, "...not apply to AveULTRA, www.aveultra.com , is mi...
(Date:11/19/2009)...ovember 19 MONITORING FORCE GmbH,a...09 Flibanserin in the,indication treatment-relevan...se for orphan drug status designation with the Eur...skinesia is a complication of the mainstay,treatme... some of those,affected, since it may be disabling...
(Date:11/19/2009)...ovember 19 AFFiRiS AG will focus i...idate at an unexpectedly early,stage of developmen...into,Phase II clinical trial early in 2010. This d...pletion of two Phase I trials with the candidates,... on the first interim,analysis of the secondary en...
(Date:11/18/2009)...lfast are developing new sensors to detect chemica...fight against the threat of terrorist attacks. , ...an individual or crime scene to gather a sample wh... can detect the presence of chemicals within secon... made in response to terrorist threats. , The s...
Breaking Biology Technology:American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3New technology detects chemical weapons in seconds 2
...ical Recoveries, FREDERICK, Md., March 13 BioEle...launch of its Breast Recovery Kit,for the relief o... by Dr. Barry Eppley, MD, DMD, the 1 Day Breast Re...n to their active lives the day,after surgery. Usi...ma and,discomfort without drugs, ice, or topical o...
...,privately-held biopharmaceutical company, announc...clinical trials sponsored by its wholly owned,subs...CollaRx(R),BUPIVACAINE SURGICAL IMPLANT for the ma...ing., Innocoll,s BUPIVACAINE SURGICAL IMPLANT is ...purified fibrillar collagen impregnated with the,l...
...ntists worldwide gain new insight i...seeks funding support for human brain, spinal cord...projects, SEATTLE, March 13 The Allen Institute ...taking three major projects designed to,accelerate...sts worldwide,gain new insight into numerous disea...
Other Biology Technology:BioElectronics Launches '1 Day Breast Augmentation Recovery Kit' 2Innocoll Announces Dosing of First Patient in a Second US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain 2Innocoll Announces Dosing of First Patient in a Second US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain 3Innocoll Announces Dosing of First Patient in a Second US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain 4Allen Institute for Brain Science Launches Three New Landmark Atlas Projects Focusing on the Human Brain, Developing Brain and Spinal Cord 2Allen Institute for Brain Science Launches Three New Landmark Atlas Projects Focusing on the Human Brain, Developing Brain and Spinal Cord 3Allen Institute for Brain Science Launches Three New Landmark Atlas Projects Focusing on the Human Brain, Developing Brain and Spinal Cord 4Allen Institute for Brain Science Launches Three New Landmark Atlas Projects Focusing on the Human Brain, Developing Brain and Spinal Cord 5
(Date:11/20/2009)...y disease (COPD), a respiratory disease commonly k...urth leading cause of death worldwide. 600 millio... yet to find any real treatment or cure, Grace Par...ty of Western Ontario in London, Canada, is using ...o the disease. , Parraga is a scientist in t...
(Date:11/19/2009)...s ago, at the end of the last ice age, North Ameri...uch iconic creatures as mammoths, mastodons, camel...their precipitous slide to extinction. , And whe... diversity of large animals equaled or surpassed A..., an entirely novel ecosystem emerged as broadleav...
(Date:11/19/2009)... = more than 2: The offspring of two inbred strain...aracterizing the gene-level variability that leads...vigor, could boost our ability to custom-tailor cr...ent for human consumption or high glucose content ...leased DNA sequence of the common corn strain B73,...
Breaking Biology News(10 mins):Gaining a better picture of lung disease 2After mastodons and mammoths, a transformed landscape 2After mastodons and mammoths, a transformed landscape 3U of M plant scientist uncovers clues to yield-boosting quirks of corn genome 2Womens Health An Intimate Discussion 51623 1Womens Health An Intimate Discussion 51623 2Johns Hopkins Medical Institutions Deploys Perceptrak 28R 29 by Cernium 51620 1Johns Hopkins Medical Institutions Deploys Perceptrak 28R 29 by Cernium 51620 2Studies Presented at International Conference on Alzheimers Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimers 13021 1Studies Presented at International Conference on Alzheimers Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimers 13021 2Studies Presented at International Conference on Alzheimers Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimers 13021 3Studies Presented at International Conference on Alzheimers Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimers 13021 4Studies Presented at International Conference on Alzheimers Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimers 13021 5Studies Presented at International Conference on Alzheimers Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimers 13021 6Studies Presented at International Conference on Alzheimers Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimers 13021 7
...ARBOR, N.Y. (Mon., Jan. 5, 2009) - This month,s i...otocols.org/TOCs/toc1_09.dtl ) features two articl... of molecular processes involved in DNA repair and...omologous recombination is an important mechanism ...occurs, a Displacement Loop, or "D-loop," is forme...
...f., January 5, 2009-- Scientists at Burnham Instit... the structure of the interactions between protein...ing complex (DISC), which is responsible for trigg...search, performed by Stefan Riedl, Ph.D., and coll... Nature , highlights how protein-protein interact...
... January 5, 2009. A recent study shows that shad...California can reduce a homeowner,s summertime ele...ucted last year on 460 single-family homes in Sacr...ity billing data to show that trees can reduce ene...s cool a house. No one is going to get a Nobel Pri...
Other Biology News:Methods for studying DNA repair and protein modification are featured in CSH Protocols 2Burnham researchers discover 'on switch' for cell death signaling mechanism 2California study shows shade trees reduce summertime electricity use 2
Pyrex brand low actinic narrow mouth Erlenmeyer flask, Pyrex ST 27 stopper from Sigma-Aldrich
Corning ultragaps Coated Slides,Bar-Coded from Sigma-Aldrich
Giemsa stain from Sigma-Aldrich
Bromothymol blue sodium salt from Sigma-Aldrich
Biology Products: